Atara Biotherapeutics Announces Presentations Highlighting Allogeneic T-Cell Immunotherapy Pipeline And CAR T Technologies At The 60th American Society of Hematology (ASH) Annual Meeting And European Society for Medical Oncology, Dec 13-16
Benzinga Newsdesk